Your browser doesn't support javascript.
loading
Chemical genomics reveals histone deacetylases are required for core regulatory transcription.
Gryder, Berkley E; Wu, Lei; Woldemichael, Girma M; Pomella, Silvia; Quinn, Taylor R; Park, Paul M C; Cleveland, Abigail; Stanton, Benjamin Z; Song, Young; Rota, Rossella; Wiest, Olaf; Yohe, Marielle E; Shern, Jack F; Qi, Jun; Khan, Javed.
Afiliação
  • Gryder BE; Genetics Branch, NCI, NIH, Bethesda, MD, 20892, USA.
  • Wu L; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
  • Woldemichael GM; Molecular Targets Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, 21701, USA.
  • Pomella S; Genetics Branch, NCI, NIH, Bethesda, MD, 20892, USA.
  • Quinn TR; Department of Oncohematology, Laboratory of Angiogenesis, Ospedale Pediatrico Bambino Gesu' Research Institute, Rome, 00165, Italy.
  • Park PMC; Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, IN, 46556, USA.
  • Cleveland A; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
  • Stanton BZ; Genetics Branch, NCI, NIH, Bethesda, MD, 20892, USA.
  • Song Y; Genetics Branch, NCI, NIH, Bethesda, MD, 20892, USA.
  • Rota R; Genetics Branch, NCI, NIH, Bethesda, MD, 20892, USA.
  • Wiest O; Department of Oncohematology, Laboratory of Angiogenesis, Ospedale Pediatrico Bambino Gesu' Research Institute, Rome, 00165, Italy.
  • Yohe ME; Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, IN, 46556, USA.
  • Shern JF; Pediatric Oncology Branch, CCR, NCI, NIH, Bethesda, MD, 20814, USA.
  • Qi J; Pediatric Oncology Branch, CCR, NCI, NIH, Bethesda, MD, 20814, USA.
  • Khan J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. jun_qi@dfci.harvard.edu.
Nat Commun ; 10(1): 3004, 2019 07 08.
Article em En | MEDLINE | ID: mdl-31285436
ABSTRACT
Identity determining transcription factors (TFs), or core regulatory (CR) TFs, are governed by cell-type specific super enhancers (SEs). Drugs to selectively inhibit CR circuitry are of high interest for cancer treatment. In alveolar rhabdomyosarcoma, PAX3-FOXO1 activates SEs to induce the expression of other CR TFs, providing a model system for studying cancer cell addiction to CR transcription. Using chemical genetics, the systematic screening of chemical matter for a biological outcome, here we report on a screen for epigenetic chemical probes able to distinguish between SE-driven transcription and constitutive transcription. We find that chemical probes along the acetylation-axis, and not the methylation-axis, selectively disrupt CR transcription. Additionally, we find that histone deacetylases (HDACs) are essential for CR TF transcription. We further dissect the contribution of HDAC isoforms using selective inhibitors, including the newly developed selective HDAC3 inhibitor LW3. We show HDAC1/2/3 are the co-essential isoforms that when co-inhibited halt CR transcription, making CR TF sites hyper-accessible and disrupting chromatin looping.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rabdomiossarcoma / Regulação Neoplásica da Expressão Gênica / Elementos Facilitadores Genéticos / Inibidores de Histona Desacetilases / Histona Desacetilases Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rabdomiossarcoma / Regulação Neoplásica da Expressão Gênica / Elementos Facilitadores Genéticos / Inibidores de Histona Desacetilases / Histona Desacetilases Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article